Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
43.9M
-
Shares change
-
+3.46M
-
Total reported value, excl. options
-
$2.05B
-
Value change
-
+$164M
-
Put/Call ratio
-
0.39
-
Number of buys
-
98
-
Number of sells
-
-76
-
Price
-
$46.77
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q1 2021
215 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.9M shares
of 69.1M outstanding shares and own 63.48% of the company stock.
Largest 10 shareholders include FMR LLC (4.82M shares), Capital Research Global Investors (2.99M shares), VANGUARD GROUP INC (2.97M shares), WELLINGTON MANAGEMENT GROUP LLP (2.81M shares), BlackRock Inc. (2.53M shares), ALLIANCEBERNSTEIN L.P. (1.98M shares), Clearbridge Investments, LLC (1.95M shares), JANUS HENDERSON GROUP PLC (1.45M shares), AMERICAN CENTURY COMPANIES INC (1.14M shares), and RIVERBRIDGE PARTNERS LLC (1.02M shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.